Royalty Pharma plc (RPRX) Reports Q4 results
Tweet
Share
E-mail
Get Alerts RPRX Hot Sheet
Price: $57.09 --0%
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
DTGI, CRMT, STZ, More
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
DTGI, CRMT, STZ, More
Join SI Premium – FREE
Royalty Pharma plc (NASDAQ: RPRX) reported Q4 Revenue for the quarter at $622 million versus the consensus estimate of $796.14 million.
For earnings history and earnings-related data on Royalty Pharma plc (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Visa, Stripe Among Firms Joining Forces on Mainstream Stablecoin - Bloomberg
- RedCloud launches AI market intelligence tool for FMCG firms in Nigeria
- Chip stocks hit record 19.7% of S&P 500, quadrupling since 2020
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
